Meet Dr. Mark Goldberg
Chair of the Department of Neurology and Neurotherapeutics
- Holder of the:
- Linda and Mitch Hart Distinguished Chair in Neurology
When Mark Goldberg, M.D., joined UT Southwestern’s Department of Neurology in 2010 as Chair, one of his initial acts was to change the department’s name to “Neurology and Neurotherapeutics” – a move that acknowledged the department’s mission to seek effective treatments for brain diseases.
“We’re at a juncture in science that will change our understanding of the causes in brain disorders, and how to treat them ,” Dr. Goldberg says. At UT Southwestern’s Peter O’Donnell Jr. Brain Institute, we’ve converged teams of experts, shared resources, and a research infrastructure to accelerate research that will result in more effective clinical care for patients. There’s no better place in the world than UT Southwestern to find new treatments for neurologic diseases.”
International stroke expert
UT Southwestern’s focus on neurosciences supports Dr. Goldberg’s fascination with the brain and its complexities. His allurement took shape early in his medical training at Columbia University and then Stanford. Now, as an internationally recognized stroke expert with more than 25 years of experience, he works with patients and in the lab to promote better and more effective recovery after a stroke.
“Patients who have had a stroke can get better. In those cases when they don’t, we use our understanding of the brain, its activity, and how it can change itself to promote better recovery and function,” Dr. Goldberg says. “Because we’re an Advanced Comprehensive Stroke Center, the only hospital in Dallas that’s received this recognition from the Joint Commission and American Stroke Association, our patients have access to truly groundbreaking care.”
Dr. Goldberg is also involved in a number of large-scale projects that bring together teams of experts across the country and throughout Texas to find better therapies for stroke. He is the UT Southwestern Director for a national initiative called NeuroNEXT, a consortium to promote access to neurologic disease clinical trials for all patients, no matter where they are located. He also serves on the executive committee of a similar initiative focused solely on Texas patients, called the Lone Star Stroke Consortium, and he co-directs UT Southwestern’s Texas Institute for Brain Injury and Repair.
“Everything I’m involved in shows my sense of hope for the future in the treatment of brain diseases and disorders – not just stroke, but also traumatic brain injury, epilepsy, Alzheimer’s disease, multiple sclerosis, and others,” Dr. Goldberg says. “There is no better time or place to be making advances that are truly important to patients.”